 |
4,5,6,7-tetrachloro-2′,4′,5′,7′-tetraiodofluorescein disodium salt |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2011-04-18 00:00:00 |
| Sponsor | Provectus Pharmaceuticals, Inc.;7327 Oak Ridge Highway;Knoxville, Tennessee, 37931 |
